highly significantp = 0.001
Patients in the azithromycin arm had a 4.4% improvement on their FEV 1 as compared to a 1.8% decrease in patients in the placebo arm—a highly significant difference ( p = 0.001).
Patients in the azithromycin arm had a 4.4% improvement on their FEV 1 as compared to a 1.8% decrease in patients in the placebo arm—a highly significant difference ( p = 0.001).